Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Mantle cell lymphoma (C83.1)
C83.1
Mantle cell lymphoma
Sub-codes (10)
- C83.10 Mantle cell lymphoma, unspecified site
- C83.11 Mantle cell lymphoma, lymph nodes of head, face, and neck
- C83.12 Mantle cell lymphoma, intrathoracic lymph nodes
- C83.13 Mantle cell lymphoma, intra-abdominal lymph nodes
- C83.14 Mantle cell lymphoma, lymph nodes of axilla and upper limb
- C83.15 Mantle cell lymphoma, lymph nodes of inguinal region and lower limb
- C83.16 Mantle cell lymphoma, intrapelvic lymph nodes
- C83.17 Mantle cell lymphoma, spleen
- C83.18 Mantle cell lymphoma, lymph nodes of multiple sites
- C83.19 Mantle cell lymphoma, extranodal and solid organ sites
Related indications (MeSH) (1)
Lymphoma, Mantle-Cell341 drugs (137 approved, 204 experimental)
A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).